Inventor · disambiguated record
Robert Pejchal
Also filed as: PEJCHAL ROBERT
13 granted patents·13 pending applications·43 citations·filing 2014–2025
90Inventor score
Top patents by PatentIndex Score
26 records- 0196US11186645B2Isolated nucleic acids encoding anti-sortilin antibodiesALECTOR LLC·Filed 2020·Granted Nov 30, 2021·4 cites·48 claims
- 0296US10676525B2Anti-TREM2 antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jun 9, 2020·13 cites·60 claims
- 0393US11208488B2Methods of increasing progranulin levels using anti-Sortilin antibodiesALECTOR LLC·Filed 2018·Granted Dec 28, 2021·4 cites·44 claims
- 0493US10711062B2Anti-CD33 antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jul 14, 2020·7 cites·77 claims
- 0591US2025092144A1Methods of use of anti-sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2024·Application pending·0 cites
- 0690US11634489B2Anti-TREM2 antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Apr 25, 2023·2 cites·32 claims
- 0790US11254743B2Anti-CD33 antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Feb 22, 2022·2 cites·20 claims
- 0890US10308718B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Jun 4, 2019·6 cites·21 claims
- 0989US11339223B2Methods of use of anti-Sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2018·Granted May 24, 2022·2 cites·59 claims
- 1088US11396546B2Anti-Sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Jul 26, 2022·2 cites·22 claims
- 1182US2025297016A1Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2025·Application pending·0 cites
- 1280US2024309097A2Methods of use of anti-sortilin antibodies for treating a disease, disorder, or injuryROSENTHAL ARNON·Filed 2022·Application pending·0 cites
- 1379US2022185899A1Methods of increasing progranulin levels using anti-sortilin antibodiesALECTOR LLC·Filed 2021·Application pending·0 cites
- 1479US2022185898A1Methods of use of anti-sortilin antibodies for treating a disease, disorder, or injuryALECTOR LLC·Filed 2021·Application pending·0 cites
- 1578US11542330B2Anti-CD3-binding domains and antibodies comprising them, and methods for their generation and useADIMAB LLC·Filed 2018·Granted Jan 3, 2023·1 cites·19 claims
- 1677US12358991B2Anti-Sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Jul 15, 2025·0 cites·52 claims
- 1777US12297277B2Anti-sortilin antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted May 13, 2025·0 cites·53 claims
- 1875US2023312712A1Anti-trem2 antibodies and methods of use thereofALECTOR LLC·Filed 2023·Application pending·0 cites
- 1971US2022162309A1Anti-cd33 antibodies and methods of use thereofALECTOR LLC·Filed 2022·Application pending·0 cites
- 2069US2023151097A1Anti-cd3-binding domains and antibodies comprising them, and methods for their generation and useADIMAB LLC·Filed 2022·Application pending·0 cites
- 2168US2022396622A1Fc variants with reduced effector functionADIMAB LLC·Filed 2022·Application pending·0 cites
- 2260US2021087271A1Fc variants with reduced effector functionADIMAB LLC·Filed 2020·Application pending·0 cites
- 2359US2025215082A1Variant ch3 domains engineered for preferential ch3 heterodimerization, multi-specific antibodies comprising the same, and methods of making thereofADIMAB LLC·Filed 2023·Application pending·0 cites
- 2452US9999664B2HIV-1 gp120 mini V3 loop and uses thereofSCRIPPS RESEARCH INST·Filed 2014·Granted Jun 19, 2018·0 cites·10 claims
- 2552US2022380463A1Engineered ph-dependent anti-cd3 antibodies, and methods for their generation and useADIMAB LLC·Filed 2020·Application pending·0 cites
- 2647US2025223379A1Variant ch3 domains engineered for preferential ch3 heterodimerization, multi-specific antibodies comprising the same, and methods of making thereofADIMAB LLC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Pejchal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →